Clinical Trials Logo

Allergy Pollen clinical trials

View clinical trials related to Allergy Pollen.

Filter by:
  • None
  • Page 1

NCT ID: NCT06167564 Not yet recruiting - Allergy Clinical Trials

Allergy Diagnostic Test Based on Microchip Technology

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to develop a microarray-based diagnostic test system for the determination of allergen specific IgE in human blood serum.

NCT ID: NCT05824637 Completed - Allergy Pollen Clinical Trials

Validation and Reproducibility of S.P.A.T. With Allergens

Start date: March 18, 2023
Phase: N/A
Study type: Interventional

To improve accuracy and take out human error opportunities, Hippo Dx developed S.P.A.T., an automated skin prick test. This study will provide a comparison between manual and automated skin prick test in allergic and non-allergic individuals with a panel of common inhalant allergens. The primary endpoint is to compare the accuracy of S.P.A.T. to detect sensitization to common aeroallergens compared to a manual skin prick test (SPT). It is a prospective monocentric study that will include 120 study participants.

NCT ID: NCT05533385 Not yet recruiting - Allergic Reaction Clinical Trials

Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.

Start date: January 2, 2023
Phase: N/A
Study type: Interventional

The objective of this study is to determine the biological activity of Juniperus oxycedrus and Cupressus arizonica. allergen extracts in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).

NCT ID: NCT05532566 Not yet recruiting - Allergic Reaction Clinical Trials

Quercus Ilex and Quercus Robur Allergen Extracts Standardisation

Start date: January 2, 2023
Phase: N/A
Study type: Interventional

The objective of this study is to determine the biological activity of Quercus illex and Quercus robur allergen extracts in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).

NCT ID: NCT05301647 Completed - Quality of Life Clinical Trials

Mometasone Furoate Nasal Spray in Italian Children

Start date: June 20, 2019
Phase:
Study type: Observational

Objective Seasonal allergic rhinitis (SAR) is a common disease in childhood and characterized by type 2 inflammation, bothersome symptoms, and impaired quality of life (QoL). Intranasal corticosteroids are effective medications in managing SAR patients. In addition, mometasone furoate nasal spray (MFNS) is a well-known therapeutic option. However, the literature provided no data about its effects in European children with SAR. Thus this study addressed this unmet need.

NCT ID: NCT03816800 Completed - Healthy Clinical Trials

Iron and Pollen Allergy in Women

Start date: January 28, 2019
Phase: N/A
Study type: Interventional

Iron deficiency and anemia are clearly associated with the onset of allergy and allergic diseases, whereas an improved iron status seems to prevent the onset of allergy in humans. Iron-deficiency can be absolute or functional. Functional iron-deficiency occurs during immune activation and may be reflective for the hyperactive state of atopic subjects. The investigators plan a prophylactic dietary intervention study in atopic/allergic and non-allergic individuals that transport chelated iron to immune cells. Over the course of six months, oral supplementation of placebo or whey protein-bound chelated iron will be given and 1) clinical reactivity 2) iron status and 3) changes in the microflora due to the treatment will be assessed.

NCT ID: NCT03514303 Recruiting - Allergy Pollen Clinical Trials

Microassay and Allergy Skin Prick Test Correlation Study

Start date: April 1, 2018
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to evaluate the potential correlation of the results of allergen-specific skin prick tests (SPT) to that of allergen-specific microarray determination (microassay test). Subjects who meet enrollment criteria, after signing an IRB approved consent form, will perform a minor finger prick blood draw and blot to be mailed off for microassay analysis. Specific statistical analysis will be done to assess all potential correlations between SPT and microassay. This study design should enable assessment of the level of correlation between SPT results and microassay results for specified allergens within a cohort of subjects with allergic rhinitis.

NCT ID: NCT03315611 Completed - Atopic Dermatitis Clinical Trials

Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis

Start date: October 2, 2017
Phase: N/A
Study type: Interventional

The objective of this study is to assess the effect of 'Eucerin AtopiControl LOTION' and 'Eucerin AtopiControl facial cream' on dermal symptoms in patients with Atopic Dermatitis (AD) after two 4 h challenges with grass pollen on two consecutive days. In addition, this clinical study with exposure of Dactyls glomerate-sensitized Patients with AD shall be used to compare the skin response with AD Patients not-sensitized to Dactylis glomerata to understand the specificity of the grass pollen exposure.